Literature DB >> 27363280

[Increased serum levels of soluble T cell immunoglobulin mucin molecule 3 and IL-4 and decreased IFN-γ in patients with pulmonary tuberculosis].

Jia Zhang1, Fengbo Zhang2, Qifeng Li3, Yunjuan Zhao3, Nan Guo4, Fan Li5, Yu Xia6, Jianbing Ding7.   

Abstract

Objective To detect the serum levels of soluble T cell immunoglobulin mucin molecule 3 (sTim-3), IFN-γ and IL-4 in patients with pulmonary tuberculosis. Methods Peripheral blood was collected from 48 patients with pulmonary tuberculosis and 20 healthy controls. The serum level of sTim-3 was detected by ELISA. The levels of IFN-γ and IL-4 were determined by cytokine bead array (CBA). The correlations between sTim-3, IFN-γ and IL-4 levels in sera of patients with pulmonary tuberculosis were analyzed by Pearson correlation test. Results Compared with the control group, the serum levels of sTim-3 and IL-4 increased significantly, while the level of IFN-γ decreased significantly. Pearson analysis showed that there was a negative correlation between sTim-3 and IFN-γ as well as between IFN-γ and IL-4 in patients with pulmonary tuberculosis, while sTim-3 and IL-4 were positively correlated. Conclusion The serum levels of sTim-3 and IL-4 increase, but IFN-γ decreases in the patients with pulmonary tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27363280

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  2 in total

1.  Increase in Serum Soluble Tim-3 Level Is Related to the Progression of Diseases After Hepatitis Virus Infection.

Authors:  Lingli Chen; Xiaomei Yu; Chunyan Lv; Yaping Dai; Tao Wang; Shaoxiong Zheng; Yuan Qin; Xiumei Zhou; Yigang Wang; Hao Pei; Hongming Fang; Biao Huang
Journal:  Front Med (Lausanne)       Date:  2022-05-12

2.  Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection.

Authors:  Fang Li; Na Li; Jiao Sang; Xiude Fan; Huan Deng; Xiaoge Zhang; Qunying Han; Yi Lv; Zhengwen Liu
Journal:  Cancer Manag Res       Date:  2018-05-01       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.